These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21322610)

  • 1. Probing the role of the mycosamine C2'-OH on the activity of amphotericin B.
    Croatt MP; Carreira EM
    Org Lett; 2011 Mar; 13(6):1390-3. PubMed ID: 21322610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant improvement of antifungal activity of polyene macrolides by bisalkylation of the mycosamine.
    Paquet V; Carreira EM
    Org Lett; 2006 Apr; 8(9):1807-9. PubMed ID: 16623556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro biological properties of novel cationic derivatives of amphotericin B.
    Paquet V; Volmer AA; Carreira EM
    Chemistry; 2008; 14(8):2465-81. PubMed ID: 18196508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycosamine orientation of amphotericin B controlling interaction with ergosterol: sterol-dependent activity of conformation-restricted derivatives with an amino-carbonyl bridge.
    Matsumori N; Sawada Y; Murata M
    J Am Chem Soc; 2005 Aug; 127(30):10667-75. PubMed ID: 16045354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biophysical studies on 35-deoxy amphotericin B methyl ester.
    Szpilman AM; Cereghetti DM; Manthorpe JM; Wurtz NR; Carreira EM
    Chemistry; 2009 Jul; 15(29):7117-28. PubMed ID: 19544513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of amphotericin B derivatives.
    Volmer AA; Szpilman AM; Carreira EM
    Nat Prod Rep; 2010 Sep; 27(9):1329-49. PubMed ID: 20556271
    [No Abstract]   [Full Text] [Related]  

  • 7. The Substantial Improvement of Amphotericin B Selective Toxicity Upon Modification of Mycosamine with Bulky Substituents.
    Borowski E; Salewska N; Boros-Majewska J; Serocki M; Chabowska I; Milewska MJ; Ziętkowski D; Milewski S
    Med Chem; 2020; 16(1):128-139. PubMed ID: 30501601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active amphotericin B derivatives position the mycosamine in two radial orientations.
    Volmer AA; Carreira EM
    Chembiochem; 2010 Apr; 11(6):778-81. PubMed ID: 20217884
    [No Abstract]   [Full Text] [Related]  

  • 9. C2'-OH of amphotericin B plays an important role in binding the primary sterol of human cells but not yeast cells.
    Wilcock BC; Endo MM; Uno BE; Burke MD
    J Am Chem Soc; 2013 Jun; 135(23):8488-91. PubMed ID: 23718627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel strategy for bioconjugation: synthesis and preliminary evaluation with amphotericin B.
    Zumbuehl A; Stano P; Sohrmann M; Peter M; Walde P; Carreira EM
    Org Biomol Chem; 2007 May; 5(9):1339-42. PubMed ID: 17464400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologically active amphotericin B-calix[4]arene conjugates.
    Paquet V; Zumbuehl A; Carreira EM
    Bioconjug Chem; 2006; 17(6):1460-3. PubMed ID: 17105224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modelling of membrane activity of amphotericin B, a polyene macrolide antifungal antibiotic.
    Baginski M; Sternal K; Czub J; Borowski E
    Acta Biochim Pol; 2005; 52(3):655-8. PubMed ID: 16086075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of amphotericin B and its selected derivatives with membranes: molecular modeling studies.
    Baginski M; Czub J; Sternal K
    Chem Rec; 2006; 6(6):320-32. PubMed ID: 17304519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactive fluorinated derivative of amphotericin B.
    Matsumori N; Umegawa Y; Oishi T; Murata M
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3565-7. PubMed ID: 15963721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-Methylglucogalloyl esters: synthesis and evaluation of their antimycotic activity.
    Romani A; Menichetti S; Arapitsas P; Nativi C; Turchetti B; Buzzini P
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4000-3. PubMed ID: 16005221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal activity of amphotericin B conjugated to carbon nanotubes.
    Benincasa M; Pacor S; Wu W; Prato M; Bianco A; Gennaro R
    ACS Nano; 2011 Jan; 5(1):199-208. PubMed ID: 21141979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anomalously high aggregation level of the polyene antibiotic amphotericin B in acidic medium: implications for the biological action.
    Gagoś M; Hereć M; Arczewska M; Czernel G; Dalla Serra M; Gruszecki WI
    Biophys Chem; 2008 Jul; 136(1):44-9. PubMed ID: 18472206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis and biological activity of hydrophosphoryl derivatives of amphotericin B].
    Belakhov VV; Shenin IuD; Arabiĭskiĭ RA; Shtil'bans EB
    Antibiot Khimioter; 1996; 41(7-8):4-8. PubMed ID: 8999761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis-enabled functional group deletions reveal key underpinnings of amphotericin B ion channel and antifungal activities.
    Palacios DS; Dailey I; Siebert DM; Wilcock BC; Burke MD
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6733-8. PubMed ID: 21368185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and characterisation of a new amphotericin B-methoxypoly(ethylene glycol) conjugate.
    Sedlák M; Buchta V; Kubicová L; Simůnek P; Holcapek M; Kasparová P
    Bioorg Med Chem Lett; 2001 Nov; 11(21):2833-5. PubMed ID: 11597410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.